With significant expertise in both drug and in vitro diagnostic development, Jane understands the priorities of both disciplines enabling her to advise on synergistic approaches to companion diagnostic development ensuring successful co-Rx/Dx approval. Jane also brings insight into the clinical deployment of CDx due to her early career as a biochemistry biomedical scientist in a clinical hospital lab, helping ensure IVDs can be readily implemented. This unique perspective enables Jane to deliver insightful solutions in support of clients needs.

Jane has successfully developed numerous IVDs which have been approved by the FDA, and CE marked. She is able to implement design control, review potential gaps in Dx processes, transfer projects to manufacturing and troubleshoot manufacturing processes. In addition, she has experience in creating diagnostic strategies for pharmaceutical companies depending on their different requirements.